Cargando…
Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey
Follicle-stimulating hormone receptor (FSHR) plays an essential role as one of the most important molecules in response to some of infertility related medications. Impaired ovarian reserve and poor response to such treatments are partially dependent on the FSHR molecule itself. However, the function...
Autores principales: | Tafazoli, Alireza, Wołczyński, Sławomir, Wawrusiewicz-Kurylonek, Natalia, Esmaeili, Seyed-Alireza, Miltyk, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825139/ https://www.ncbi.nlm.nih.gov/pubmed/33561079 http://dx.doi.org/10.3390/jcm10020170 |
Ejemplares similares
-
Pharmacogenomics, How to Deal with Different Types of Variants in Next Generation Sequencing Data in the Personalized Medicine Area
por: Tafazoli, Alireza, et al.
Publicado: (2020) -
Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing data
por: Tafazoli, Alireza, et al.
Publicado: (2022) -
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
por: Tafazoli, Alireza, et al.
Publicado: (2021) -
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021) -
Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
por: Miltyk, Wojciech, et al.
Publicado: (2022)